African Americans: Avoid Infections or Risk a Stroke; polyDNA Recommends Gene-Eden-VIR against Latent Viral Infections

A study published on February 7, 2014 in the journal Neurology found that “Acute infection disproportionately increases the risk of stroke death for non-Hispanic blacks (1).” polyDNA reviews the literature and recommends Gene-Eden-VIR to help the immune system target latent viral infections.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
African Americans are already at a high risk for stroke due to factors such as high blood pressure and diabetes. Research clearly shows that previous infections increase this risk even further. - Mike Evans, polYDNA

Rochester, NY (PRWEB) February 25, 2014

Research shows that African Americans are more likely to die from a stroke following an infection (1). “Researchers analyzed data on older Americans in the U.S. Health and Retirement Study, and found that blacks were 39 times more likely to die of a stroke if they’d had an infection in the previous month.” (See the U.S. News & World Report, from February 12, 2014) (2). Infection with Herpes Zoster (HZ) has been linked to both heart disease and stroke. Herpes Zoster, a condition caused by the Varicella Zoster Virus (VZV), increases the risk of transient ischemic attacks (an injury in the brain), (and) for stroke….” (See the journal Neurology, from January 21, 2014) (3). polyDNA therefore recommends that African Americans consider taking Gene-Eden-VIR. This natural product was clinically proven to reduce symptoms of viral infections in a study that followed FDA guidelines.

Dr. Deborah Levine said, “Infection before stroke appears to be most lethal for black Americans.” In addition, “The study also found that 70 percent of blacks who died of a stroke had an infection within the previous 30 days, compared with 45 percent of whites who died of a stroke. Among blacks and whites who did not die of stroke, infection rates in the previous months were 15 percent and 19 percent, respectively (2).” In other words, African Americans are much more sensitive to the detrimental effects of an infection.

African American women may especially be at risk. “The rate of stroke in African-American women is almost twice that of white women. African-American women also have a higher risk of dying from a stroke than white women.” (See WomensHealth.gov, from May 18, 2010) (4). All African American stroke survivors “are more likely to become disabled and experience difficulties with daily living and activities.” (See Stroke.org) (5).

Infection with the VZV virus increases the risk of stroke, transient ischemic attack, and heart attack dramatically. “HZ is an independent risk factor for vascular disease … particularly for stroke (3).”

“Shingles is caused by the Varicella Zoster Virus, the same virus that causes chickenpox. After a person recovers from chickenpox, the virus stays in the body in a dormant (inactive) (latent) state. For reasons that are not fully known, the virus can reactivate years later, causing shingles.” (See the CDC’s website last updated on January 10, 2011) (6).

“African Americans are already at a high risk for stroke due to factors such as high blood pressure and diabetes. Research clearly shows that previous infections increase this risk even further. We therefore recommend Gene-Eden-VIR, a natural antiviral that was proven to be safe and effective in a clinical study that followed FDA guidelines.” – Mike Evans, polyDNA

In a post marketing clinical study published on August 12, 2013 in the medical journal Pharmacology & Pharmacy in a special edition on Advances in Antiviral Drugs, researchers showed that Gene-Eden-VIR is safe and effective (7). Additionally, up to 70% of those studied reported a decrease in viral symptoms, and users experienced an increase in overall health (7).

Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target latent viruses (7).

To learn more about Gene-Eden-VIR and herpes, visit: http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

Reference:

(1) Acute infection contributes to racial disparities in stroke mortality. Published on February 7, 2014.
http://www.ncbi.nlm.nih.gov/pubmed/24510494

(2) Infection-Triggered Strokes Deadlier for Blacks, Study Finds. Published on February 12, 2014.
http://health.usnews.com/health-news/articles/2014/02/12/infection-triggered-strokes-deadlier-for-blacks-study-finds

(3) Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK. Published on January 21, 2014.
http://www.ncbi.nlm.nih.gov/pubmed/24384645

(4) WomensHealth.gov - Minority Women's Health. Last updated May 18, 2010
http://womenshealth.gov/minority-health/african-americans/stroke.html

(5) Stroke.org - African Americans and Stroke.
http://www.stroke.org/site/PageServer?pagename=aamer

(6) CDC - Shingles (Herpes Zoster). Last updated January 10, 2011.
http://www.cdc.gov/shingles/about/overview.html

(7) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing
Clinical Study. Published on August 12, 2013.
http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.